Author:
Meneses ,Silvestre ,Sousa-Lima ,Macedo
Abstract
Metabolic disorders are characterized by an overall state of inflammation and oxidative stress, which highlight the importance of a functional antioxidant system and normal activity of some endogenous enzymes, namely paraoxonase-1 (PON1). PON1 is an antioxidant and anti-inflammatory glycoprotein from the paraoxonases family. It is mainly expressed in the liver and secreted to the bloodstream, where it binds to HDL. Although it was first discovered due to its ability to hydrolyze paraoxon, it is now known to have an antiatherogenic role. Recent studies have shown that PON1 plays a protective role in other diseases that are associated with inflammation and oxidative stress, such as Type 1 and Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. The aim of this review is to elucidate the physiological role of PON1, as well as the impact of altered PON1 levels in metabolic disorders.
Funder
Sociedade Portuguesa de Diabetologia
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference196 articles.
1. Obesity and Overweighthttp://www.who.int/mediacentre/factsheets/fs311/en/
2. Cardiovascular Diseases (CVDs)http://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
3. Diabeteshttp://www.who.int/news-room/fact-sheets/detail/diabetes
4. Increased oxidative stress in obesity and its impact on metabolic syndrome
5. NF-κB, Inflammation, and Metabolic Disease
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献